Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Relate News
10/4/2023
Sales Expenses of 489 Chinese Pharma Cos Exceed CNY 170B in H1/2023
10/3/2023
CNIPA Invalides Novo's Core Chinese Patent for Semaglutide as Petition...
10/3/2023
As Another New Normal of China Healthcare Dawns, Pharma MNCs Need to C...
9/29/2023
CDE Solicits Comments on the Technical Guidelines for Pharmaceutical R...
9/29/2023
CDE Solicits Comments on the Technical Guidelines for the Study of Ove...
9/29/2023
CDE Solicits Comments on the Technical Guidelines for Pharmaceutical R...
9/29/2023
Recent Executive Moves
9/29/2023
Drug R&D and Product Registration News Digest 09/2023 (4)
9/29/2023
Financial-related Company News Digest (September 2023)
9/29/2023
CDE Solicits Comments on the Technical Guidelines for Pharmaceutical R...
9/28/2023
Chime Biologics Enters Strategic Deal with Kings Pharm to Accelerate B...
9/28/2023
CDE Solicits Comments on the Technical Guidelines for Pharmaceutical R...
9/28/2023
CDE Solicits Comments on the Technical Guidelines for Clinical Efficac...
9/28/2023
CDE Issues on the Technical Guidelines for Clinical Trials of Dry Eye ...
9/28/2023
CDE Issues on the Technical Guidelines for Clinical Trials of Multiple...
9/28/2023
CDE Issues on the Technical Guidelines for Clinical Trials of Lupus Ne...
9/28/2023
CDE Issues on the Technical Guidelines for Clinical Trials of Drugs fo...
9/28/2023
Overview of Recent Anti-Corruption Enforcement Actions in the Pharmace...
9/27/2023
CDE Issues the Technical Guidelines for Non-clinical Research of Antib...
9/26/2023
China's Shifting Cost Dynamic to Help It Develop Own Biologics Niche: ...
9/26/2023
China Becomes Country with Highest and Increasingly Younger Alzheimer ...
9/26/2023
CDE Solicits Comments on the Technical Guidelines for the Assessment o...
9/26/2023
SAMR Imposed Fines and Confiscations Totaling Over CNY 300 Million in...
9/26/2023
Control Dispute with Hengrui Led to Dissolution Drama of Reistone Biop...
9/26/2023
Chinese Patents of Four MNC Originator Drugs Face Imminent Invalidatio...
9/26/2023
WuXi Debuts First Vaccine CDMO Site in China
9/26/2023
Patent Linkage In China: What The First Decisions Reveal About The Dir...
9/26/2023
AstraZeneca Looks To China For Growth - But CEO Says Spinoff Not Happe...
9/25/2023
CDE Solicits Comments on the Acceptance and Review Guide to GQCE Studi...
9/25/2023
CDE's Annual Review of Chinese Drug Evaluation and Registration in 202...
Page:
103
/
790
Total number of articles:
23678
:
[First]
[<<]
[101]
[102]
[103]
[104]
[105]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit